Drug · DIN 02230451
MITOMYCIN FOR INJECTION
SINGLE-DOSE VIAL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since September 27, 2012; first marketed October 22, 1997.
- Drug Identification Number (DIN)
- 02230451
- Company (DIN owner)
- Teva Canada LimitedToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Powder For Solution
- Route
- Intravenous; Intravesical
- Therapeutic class (ATC)
- Mitomycin L01DC03
- Class
- Human
- Record last updated
- August 7, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| MITOMYCIN | 20 MG | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 26, 2012: NOC 13677New Drug Submission (NDS) · Manufacturer name change
- January 8, 1997: NOC 6029New Drug Submission (NDS)
Other DINs named MITOMYCIN FOR INJECTION
- DIN 02230450 · Cancelled Post Market
- DIN 02557762 · Approved